Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2025 09:00 ET | Source: General Oncology, Inc.

General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer

BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced...
March 06, 2025 13:00 ET | Source: DelveInsight Business Research LLP

TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight

New York, USA, March 06, 2025 (GLOBE NEWSWIRE) -- TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight T-cell...
March 04, 2025 08:30 ET | Source: Irazu Oncology

Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities

Dr. Mayukh Das, joined Irazú as CMO, bringing extensive oncology drug development experience from leadership roles at global pharmaceutical companies.
March 04, 2025 08:00 ET | Source: Mestag Therapeutics Ltd.

Mestag Therapeutics Appoints Dr. Matthew Sleeman as Chief Scientific Officer

CAMBRIDGE, United Kingdom, March 04, 2025 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease...
February 27, 2025 13:00 ET | Source: DelveInsight Business Research LLP

WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight

New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight The WEGOVY market has experienced significant...
February 25, 2025 13:00 ET | Source: DelveInsight Business Research LLP

LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight

New York, USA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight The...
February 25, 2025 07:30 ET | Source: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q4 2024 and full year 2024 net product revenue of $122.5 million and $417.0 million, respectively –– ARCALYST 2025 net product revenue expected to be $560 - $580 million ––...
February 25, 2025 07:29 ET | Source: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy

– Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025 – – KPL-387 Phase 1 single ascending dose data support potential monthly dosing – – Kiniksa...
February 24, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Photodynamic Therapies in Oncology Market is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight

New York, USA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Photodynamic Therapies in Oncology Market is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight The market...
February 21, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Evolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight

New York, USA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Evolving Landscape of Obesity: Key Market Insights of Latest Published Different Types of Obesity | DelveInsight The obesity market size is...